Is Amanita muscaria safe?
Amanita muscaria
Amanita muscaria, the red-and-white fly agaric, is sold as gummies, chocolates and capsules marketed as legal psychedelics. The FDA says it is not generally recognised as safe and treats foods containing it as adulterated. Products often contain other drugs or none of the active compounds.
- FDA status in food
- Not GRAS; unapproved food additive (December 2024)
- FDA status in supplements
- New dietary ingredient without safety data; warning letter (September 2025)
- Active compounds
- Ibotenic acid and muscimol (GABA-acting), plus small amounts of muscarine
- Diamond Shruumz outbreak (2024)
- 180 ill in 34 states, 73 hospitalised, 2 deaths (CDC)
- Mushroom per product, online gummies
- 2,000 mg to 8,000 mg (average 4,182 mg)
- Federal scheduling
- Not a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary in the US
- Banned or controlled in
- Louisiana (since 2005), the Netherlands, Romania, Poland, Lithuania
How the score breaks down
The overall score is the weighted average of these factors. Scoring rules
Safety at usual doses25% of score
30 out of 100, PoorThe FDA says eating A. muscaria causes stomach upset, delirium and sleepiness, with convulsions and coma after large exposures such as extracts. Products sold online list 2,000 mg to 8,000 mg of mushroom, and potency varies with season and processing.
Organ toxicity reports20% of score
45 out of 100, WeakHarm falls on the brain rather than the liver, unlike death cap poisoning. Deaths are rare, about 2% to 5% of reported accidental poisonings in older series. In the 2024 Diamond Shruumz outbreak, 38 people needed intensive care and 2 died.
Interactions20% of score
45 out of 100, WeakMuscimol acts on GABA-A receptors, so alcohol, benzodiazepines, sleeping pills and other sedatives can add to drowsiness and slowed breathing. Mixing other substances raised admission rates in poison centre data from 2023 to 2024.
Product quality20% of score
15 out of 100, PoorFDA testing of Diamond Shruumz products found muscimol in some and psilocin, pregabalin and kavalactones in others. Two Oregon gummies labelled as Amanita had no muscimol or ibotenic acid but contained psilocin.
Regulatory actions15% of score
15 out of 100, PoorIn December 2024 the FDA said A. muscaria and muscimol, ibotenic acid and muscarine are not GRAS and are unapproved food additives. It warned a supplement seller in 2025. Louisiana and several European countries ban or control it.
Is Amanita muscaria safe?
No. Amanita muscaria, the red-and-white fly agaric of fairy tales, is a poisonous mushroom. Its main compounds, ibotenic acid and muscimol, act on the brain's GABA system and cause confusion, agitation, dream-like delirium and deep sleep. In recent years it has been sold in smoke shops and online as gummies, chocolates, capsules and tinctures, marketed as a "legal" alternative to magic mushrooms or as a sleep and anxiety aid.
It scores 31, a little above kratom at 29 and phenibut at 25. It does not carry their risk of dependence. It scores this low because the FDA says it is not safe in food, poisonings are common, and what is in a given gummy is often unknown.
What the FDA says
On 18 December 2024, after reviewing adverse event reports and inquiries from state regulators, the FDA told manufacturers that A. muscaria, its extracts and its constituents muscimol, ibotenic acid and muscarine "do not meet the Generally Recognized as Safe (GRAS) standard and are unapproved food additives". It said there is "not enough safety evidence to show the consumption of these substances as food ingredients would be safe", that food containing them is adulterated, and that people should "avoid eating foods with these ingredients".
The letter also described what the agency was seeing. Its adverse event system had received reports of "central nervous system depression, drowsiness, seizures, and hospitalizations", and a poison centre query found "hundreds of calls in the last year", with effects including heart problems, hallucinations, slowed breathing and death.
Supplements followed. In September 2025 the FDA sent a warning letter to Blue Forest Farms, which sold A. muscaria capsules, a tincture and a chocolate. It said the mushroom and its compounds are new dietary ingredients with no evidence they were sold before 1994, that there was not enough safety data, and it named "delirium, seizures, coma, respiratory depression, and death" among the concerns.
The mushroom is not federally controlled, but Louisiana has banned it since 2005, and the Netherlands, Romania, Poland and Lithuania control it or prohibit its sale.
The Diamond Shruumz outbreak
The case that brought this market to national attention was Diamond Shruumz, a brand of "microdosing" chocolate bars, cones and gummies. In 2024, CDC and the FDA linked mushroom-containing chocolates to 180 illnesses in 34 states. Seventy-three people were hospitalised, 38 needed intensive care, 29 needed a breathing tube and 2 died. Eating Diamond Shruumz bars raised the odds of seizures about eight-fold compared with other mushroom chocolates. The maker, Prophet Premium Blends, recalled all its products in June 2024.
FDA testing showed why the effects were so varied. Some bars and cones contained muscimol, and the raw ingredient contained ibotenic acid and muscimol. Others contained psilocin (a Schedule I drug), the prescription drug pregabalin and kava compounds. Contents differed even between samples of the same flavour.
Do the gummies contain what they say?
Often not. A 2025 study of eight mushroom gummies bought in Portland, Oregon smoke shops found no ibotenic acid or muscimol in the two products labelled as A. muscaria extract; both contained psilocin and related tryptamines instead. A separate analysis of 27 consumer products found no ibotenic acid in any of the 11 gummies claiming Amanita extract, psilocybin in one labelled "no psilocybin", and none of the tested compounds at all in five products.
Doses are large and vague. A study of the 13 most-visited online retailers in April 2025 found gummies listing an average of 4,182 mg of mushroom per product, from 2,000 mg to 8,000 mg, and some also contained THC. Muscimol content in the mushroom itself varies by season, region and how it is dried or cooked, so no label can give a reliable dose.
What poisoning looks like
Symptoms usually start 30 minutes to 3 hours after eating: nausea and vomiting, then confusion, dizziness, muscle twitching, distorted perception and hallucinations, followed by lethargy and deep sleep. Large amounts, extracts and isolated compounds can cause seizures and coma, according to the FDA. Most cases resolve within hours. Deaths are rare; a 2025 review puts mortality at about 2% to 5% of reported accidental poisonings, mainly in older literature.
Older adults, children and people with heart disease are more vulnerable. Muscimol's sedating effect adds to that of alcohol, benzodiazepines such as alprazolam, sleeping pills and other sedatives, and US poison centre data from 2023 to 2024 found that mixing substances with mushroom edibles more than doubled the odds of hospital admission.
What to do
Avoid Amanita muscaria products. If you or someone else has taken one and becomes very confused, agitated, hard to wake, has a seizure or is breathing slowly, call 911. For advice on a suspected poisoning, call Poison Help at 1-800-222-1222 (US) and keep the package, since the label may not match what is inside. Children who eat gummies by accident need to be checked by a doctor even if they seem well.
If you were looking at these products for sleep or anxiety, talk to your doctor or pharmacist about options with safety data.
How we scored it
Product quality (15) and regulatory actions (15) are the weakest factors: products contain other drugs or none of the expected compounds, and the FDA rejects the mushroom in both food and supplements. Dose safety (30) reflects delirium, seizures and coma at amounts sold. Organ toxicity (45) and interactions (45) are higher because harm falls on the brain rather than the liver, and there is no dependence.
Questions people ask
Are Amanita muscaria gummies legal?
The mushroom is not a federally Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary, but the FDA said in December 2024 that it is not safe for use in food, so gummies and chocolates containing it are adulterated and subject to enforcement. In 2025 the FDA also warned a seller that it cannot be sold as a supplement without safety data. Louisiana bans it, and so do several European countries.
Is Amanita muscaria the same as magic mushrooms?
No. Magic mushrooms contain psilocybin, a Schedule I drug. Amanita muscaria contains ibotenic acid and muscimol, which act on the brain's GABA system and cause sedation, confusion and dream-like delirium. Tests show some gummies sold as Amanita contain psilocin instead.
Can Amanita muscaria kill you?
Deaths are rare but documented, and the FDA lists death among reported effects. Most poisonings cause vomiting, confusion, agitation or deep sleep and resolve within hours. It is far less lethal than the death cap, a related Amanita that destroys the liver.
How long does Amanita muscaria poisoning last?
Symptoms usually start 30 minutes to 3 hours after eating, and most cases resolve within hours. Severe cases with seizures or coma need hospital care. If someone is hard to wake, having a seizure or breathing slowly, call 911; for advice, call Poison Help at 1-800-222-1222 (US).
Does boiling or drying make Amanita muscaria safe?
Drying and heating can convert ibotenic acid to muscimol, which changes the balance of effects, but no preparation has been shown to make it safe. Potency varies widely between mushrooms, seasons and batches, so the dose is unpredictable either way.
Sources
- 1.FDA alerts industry and consumers about the use of Amanita muscaria or its constituents in food (opens in a new tab) · US Food and Drug Administration, 2024
- 2.Letter to industry on the use of Amanita muscaria or its constituents in food (opens in a new tab) · US Food and Drug Administration, 2024
- 3.Investigation of illnesses, Diamond Shruumz-brand chocolate bars, cones and gummies (June 2024) (opens in a new tab) · US Food and Drug Administration, 2024
- 4.Severe illness associated with eating mushroom-containing chocolate products, United States, January–October 2024 (opens in a new tab) · CDC MMWR, 2026
- 5.Blue Forest Farms LLC warning letter (opens in a new tab) · Food Safety News (reporting an FDA warning letter), 2025
- 6.Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon (opens in a new tab) · Clinical Toxicology, 2025
- 7.Acute Amanita muscaria toxicity: a literature review and two case reports (opens in a new tab) · Toxins, 2025
- 8.Amanita muscaria as a novel psychoactive substance: toxicological risks and clinical implications (opens in a new tab) · Frontiers in Pharmacology, 2026